Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:7) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 37.4 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 42.8 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 48.3 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 59.8 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 66.6 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 69.6 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 72.7 | pmol/sample |
| - | PE(40:7) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 64.3 | pmol/sample |
| - | PE(40:7) | C | 0.0 | BCD100322A01 | 90.7 | pmol/sample |
| - | PE(40:7) | C | 0.5 | BCD100322A03 | 48.8 | pmol/sample |
| - | PE(40:7) | C | 1.0 | BCD100322A07 | 57.4 | pmol/sample |
| - | PE(40:7) | C | 2.0 | BCD100322A11 | 73.5 | pmol/sample |
| - | PE(40:7) | C | 4.0 | BCD100322A15 | 60.1 | pmol/sample |
| - | PE(40:7) | C | 8.0 | BCD100322A19 | 79.8 | pmol/sample |
| - | PE(40:7) | C | 12.0 | BCD100322A23 | 90 | pmol/sample |
| - | PE(40:7) | C | 24.0 | BCD100322A27 | 74.6 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 49.8 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 100 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 106 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 63.9 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 65.4 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 57.3 | pmol/sample |
| - | PE(40:7) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 73.4 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 0.5 | BCD100322A04 | 45.6 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 1.0 | BCD100322A08 | 67.8 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 2.0 | BCD100322A12 | 77 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 4.0 | BCD100322A16 | 78 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 8.0 | BCD100322A20 | 90.3 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 12.0 | BCD100322A24 | 80.9 | pmol/sample |
| - | PE(40:7) | 25OH-Chol | 24.0 | BCD100322A28 | 122 | pmol/sample |